HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.

Abstract
Increasing indication is unveiling a role for poly(ADP-ribose) polymerase (PARP)-1 in the regulation of inflammatory/immune responses. The aim of the present study was to determine the potential anti-inflammatory effects of PARP-1 inhibitor 5-aminoisoquinolinone (5-AIQ) to explore the role of PARP-1 inhibitor in a mouse model of carrageenan-induced lung inflammation. A single dose of 5-AIQ (1.5mg/kg) was administered intraperitoneally (i.p.) 1h before λ-carrageenan (Cg) administration. We assessed the effects of 5-AIQ treatment on CD25(+), GITR(+), CD25(+)GITR(+), IL-17(+) and Foxp3(+) cells which were investigated using flowcytometry in pleural exudates and heparinized blood. We also evaluated mRNA expressions of IL-6, TNF-α, IL-1β, IL-10, CD11a, l-selectin (CD62L), ICAM-1, MCP-1, iNOS and COX-2 in the lung tissue. We further examined the effects of 5-AIQ on the key mediators of inflammation, namely COX-2, STAT-3, NF-kB p65, PARP-1, IkB-α and IL-4 protein expression in the lung tissue using western blotting. The results illustrated that the numbers of T cell subsets, IL-17(+) cytokine levels were markedly increased and Foxp3(+) production decreased in the Cg group. Furthermore, Cg-induced up-regulation of adhesion molecules, pro-inflammatory mediators and chemokine expressions. Western blot analysis revealed an increased protein expressions of COX-2, STAT-3 NF-kB p65 and PARP-1 and decreased IkB-α and IL-4 in the Cg group. PARP-1 inhibitor via 5-AIQ treatment reverses the action significantly of all the previously mentioned effects. Moreover, histological examinations revealed anti-inflammatory effects of 5-AIQ, whereas Cg-group aggravated Cg-induced inflammation. Present findings demonstrate the potent anti-inflammatory action of the PARP-1 inhibitor in acute lung injury induced by carrageenan.
AuthorsSheikh Fayaz Ahmad, Khairy M A Zoheir, Mushtaq Ahmad Ansari, Hesham M Korashy, Saleh A Bakheet, Abdelkader E Ashour, Othman A Al-Shabanah, Mohammed M Al-harbi, Sabry M Attia
JournalMolecular immunology (Mol Immunol) Vol. 63 Issue 2 Pg. 394-405 (Feb 2015) ISSN: 1872-9142 [Electronic] England
PMID25304310 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • 5-aminoisoquinolinone
  • Cell Adhesion Molecules
  • Cytokines
  • Enzyme Inhibitors
  • Forkhead Transcription Factors
  • Foxp3 protein, mouse
  • Glucocorticoid-Induced TNFR-Related Protein
  • Inflammation Mediators
  • Interleukin-17
  • Interleukin-2 Receptor alpha Subunit
  • Isoquinolines
  • Poly(ADP-ribose) Polymerase Inhibitors
  • RNA, Messenger
  • Tnfrsf18 protein, mouse
  • Carrageenan
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Poly(ADP-ribose) Polymerases
Topics
  • Animals
  • Carrageenan
  • Cell Adhesion Molecules (genetics, metabolism)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Cytokines (genetics, metabolism)
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Female
  • Forkhead Transcription Factors (metabolism)
  • Gene Expression Regulation (drug effects)
  • Glucocorticoid-Induced TNFR-Related Protein (metabolism)
  • Inflammation Mediators (metabolism)
  • Interleukin-17 (biosynthesis)
  • Interleukin-2 Receptor alpha Subunit (metabolism)
  • Isoquinolines (pharmacology, therapeutic use)
  • Lipid Peroxidation (drug effects, genetics)
  • Mice, Inbred BALB C
  • Nitric Oxide Synthase Type II (genetics, metabolism)
  • Pneumonia (drug therapy, enzymology, pathology)
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • T-Lymphocytes, Regulatory (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: